Sesen Bio Reports Second Quarter 2018 Financial Results and Pipeline Updates

Jounce Therapeutics Reports Second Quarter 2018 Financial Results

Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results

Magenta Therapeutics Reports Recent Operational Progress and Second Quarter 2018 Financial Results

Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-Muscle Invasive Bladder Cancer